Balancing regulation and innovation in laboratory-developed tests
The new proposed rule published in October 2023 states the FDA’s intention to regulate LDTs, including those that are manufactured by a laboratory.
Analyst Comment
Empowering healthcare: The rise of home-based medical devices in ageing populations
World AIDS Day: USA’s HIV testing rebound post-Covid
Impact on spinal fixation market due to recent FDA approvals
Online marketplace risk: FDA recalls stolen laryngoscopes
Wearable technology growing in importance for medical uses
Reducing cost of next-generation sequencing: unlock personalised medicine
First human clinical trial using CRISPR to lower cholesterol levels
